2024 asa guidance glp-1 receptor agonists perioperative like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These GLP-1 Receptor Agonists And Aspiration

Description

Society guidelines have left clinicians with some questionable recommendations

bimagrumab) may improve the body composition during WL and are in early phase clinical trials

With the increasing use of Glucagon-Like Peptide-1 Receptor (GLP-1R) agonists for diabetes management and weight loss, their implications in perioperative care have gained attention

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity